GLP-1 Over the Counter: What You Need to Know

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 medications have transformed weight management for millions of people, but they remain prescription-only drugs—not available over the counter. The FDA classifies semaglutide and tirzepatide as controlled medications because they require medical oversight to ensure safe dosing and monitoring. PlexusDx connects patients with licensed 503A compounding pharmacies that prepare these medications under doctor supervision, delivering prescription-strength therapy without the traditional insurance barrier.

Why GLP-1 Medications Aren't Over the Counter

Semaglutide and tirzepatide are FDA-regulated prescription drugs because they activate specific receptor pathways in the brain and pancreas that affect blood sugar, appetite, and weight. These mechanisms require individualized dosing that starts low and increases gradually over weeks or months—a protocol that demands medical evaluation and ongoing monitoring. Over-the-counter status would eliminate the safeguards that prevent adverse events like pancreatitis, thyroid concerns, or dehydration in vulnerable populations.

The FDA has never approved any GLP-1 medication as an OTC product, and compounded versions—while legal when prepared by licensed 503A pharmacies—are still prescription medications requiring a doctor's order. This regulatory framework exists because GLP-1 drugs work on multiple biological systems and individual responses vary based on genetics, kidney function, and medication interactions. Patients seeking GLP-1 therapy must obtain a prescription from a licensed healthcare provider, though the process has become faster and more accessible through telehealth platforms like PlexusDx.

Compounded GLP-1 vs. Brand-Name Alternatives

Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are manufactured by pharmaceutical companies and distributed through traditional pharmacies, but their costs often exceed $900–$1,400 per month even with insurance coverage. PlexusDx sources compounded semaglutide from licensed 503A pharmacies at $149 per month, and compounded tirzepatide at $249 per month—both flat-rate pricing regardless of dose escalation. Compounded medications contain identical active ingredients and undergo quality testing, but cost significantly less because they bypass corporate supply chains and marketing expenses.

The difference between brand-name and compounded GLP-1 therapy is primarily economic and logistical, not clinical. Both require a prescription, both activate the same GLP-1 receptor, and both follow identical dosing protocols starting at low amounts and increasing every four weeks. PlexusDx offers compounded formulations through telehealth providers who evaluate candidates, write prescriptions, and coordinate with licensed compounding pharmacies in all 50 states—making access faster and more affordable than waiting for retail pharmacy availability or negotiating insurance coverage.

How to Access Prescription GLP-1 Therapy Without Insurance

PlexusDx eliminates the need for insurance coverage by working directly with patients and licensed compounding pharmacies, accepting cash payment and HSA/FSA funds. The enrollment process begins with a brief telehealth consultation where a provider reviews your medical history, current medications, and weight loss goals—typically completed within 24 hours. Once approved, PlexusDx coordinates with a licensed 503A pharmacy to prepare your personalized compound, which ships directly to your home with full dosing instructions and injection supplies.

Pricing for compounded semaglutide injections starts at $149 per month, and your dose may increase over eight weeks without any price increase—a model PlexusDx calls 'your dose may go up, your price won't.' Patients receive ongoing telehealth support, prescription refills, and dose adjustments at no additional cost. The entire process is transparent: no hidden membership fees, no insurance verification delays, and no surprise charges based on dose level.

Personalization Through Genetic Testing

Individual responses to GLP-1 therapy vary significantly based on genetic factors affecting appetite regulation, glucose metabolism, and peptide sensitivity. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after the first month) which analyzes 14 metabolic pathways and 150+ genetic insights, including key variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609. These genetic markers help predict which GLP-1 formulation—semaglutide, tirzepatide, or dual-compound GLP-Squared—may deliver optimal results for your unique biology.

The genetic test informs whether you're a stronger responder to single GLP-1 agonists or might benefit from combination therapy with tirzepatide, which activates both GLP-1 and GIP receptors. This personalization extends beyond medication selection to dosing speed and side effect anticipation, allowing your PlexusDx provider to tailor your protocol from day one. Genetic insights also help explain why your neighbor's results on semaglutide differ from yours—biology, not willpower, drives much of the variation in weight loss outcomes.

Safety and Medical Oversight Without High Costs

Compounded GLP-1 medications prepared by licensed 503A pharmacies maintain the same pharmaceutical standards as brand-name versions, including sterility testing, potency verification, and quality assurance audits. PlexusDx providers conduct initial health screening and monthly check-ins to monitor side effects, adjust doses, and address any concerns—providing medical oversight equivalent to traditional clinics at a fraction of the cost. Patients receive clear guidance on injection technique, medication storage, and when to seek emergency care.

Common side effects like nausea and constipation typically subside within 2–4 weeks as your body adjusts to the medication. PlexusDx providers can recommend timing adjustments, dietary modifications, or over-the-counter remedies to ease the transition. Serious adverse events are rare when patients follow dosing protocols and maintain hydration, but your telehealth provider remains available to address any red flags and escalate care if needed.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I buy semaglutide or tirzepatide without a prescription?

No—all GLP-1 medications are prescription drugs in the United States, including compounded versions. You must obtain a prescription from a licensed healthcare provider. PlexusDx streamlines this process through telehealth evaluation and coordination with licensed compounding pharmacies, making prescription access faster and more affordable than ...

Are compounded GLP-1 medications as effective as brand-name versions?

Yes. Compounded semaglutide and tirzepatide contain identical active ingredients and follow the same dosing protocols as Ozempic, Wegovy, Mounjaro, and Zepbound. The primary difference is cost: PlexusDx compounded semaglutide starts at $149/month versus $900+ for brand-name alternatives. Both require medical oversight and produce equivalent weig...

How much does PlexusDx GLP-1 therapy cost per month?

Compounded semaglutide injections start at $149 per month, and compounded tirzepatide injections start at $249 per month—both at flat rates regardless of dose level. Optional genetic testing is $99 after your first month. PlexusDx accepts HSA/FSA funds and requires no insurance, membership fee, or hidden charges.

What are the main side effects of GLP-1 therapy?

Most patients experience mild nausea, constipation, or reduced appetite during the first 2–4 weeks as their body adjusts. These effects typically diminish over time. Serious side effects are uncommon but can include pancreatitis or dehydration if dosing guidelines aren't followed. Your PlexusDx provider monitors for any concerns during monthly t...

Can genetic testing help me choose between semaglutide and tirzepatide?

Yes. PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and metabolic response. These insights help your provider recommend whether single GLP-1 agonist therapy (semaglutide) or dual-mechanism tirzepatide may deliver better results for your genetics, optimizing outcome...

Can I Get GLP-1 Over the Counter? Understanding Your Options